Insiders · Profile

Taylor Ben R

Chief Financial Officer at RECURSION PHARMACEUTICALS. Filing since 29 Dec 2025. CIK 0001712276

Company
Date
Role
Action
Shares
Amount
Of holding
17 Mar 2026
Chief Financial Officer
Sold on a plan
7,956
$26.97K
0.7%
18 Feb 2026
Chief Financial Officer
Sold on a plan
13,426
$41.35K
1.1%
29 Dec 2025
Chief Financial Officer
Sold on a plan
21,383
$89.38K
2.7%
3 decisions on file.